Navigation Links
US Oncology Encourages Your Right to Decide
Date:4/13/2009

April 16, National Healthcare Decisions Day, your choice in times of despair

HOUSTON, April 13 /PRNewswire/ -- US Oncology, Inc.(www.usoncology.com), supporting the nation's foremost cancer treatment and research network working with providers, payers and manufacturers to advance cancer care in America, is encouraging all Americans to get involved in National Healthcare Decisions Day (www.nationalhealthcaredecisionsday.org).

April 16 is designated as the day every single American should take time to make his or her thoughts and wishes known about personal healthcare in light of an unexpected, catastrophic event. It is also about having these same conversations with parents and grandparents to ensure understanding of what they want their care to look like later in life. No one wants to have to guess at another's decision for healthcare.

"Advance care planning is the best gift you can give to your family," says Dr. Russell Hoverman, physician with Texas Oncology (www.texasoncology.com), an affiliated practice of US Oncology. "With advance directives like a living will or a healthcare power of attorney, no one has to make the tough decisions; they simply have to act on your personal wishes and not wonder if they made the right choice."

Many Americans have wills to direct property and assets after death. Yet few have living wills or healthcare powers of attorney, and few have ever talked to their loved ones about the kind of medical treatments they want and do not want in cases when they are not able to direct their own care. Each state has its own forms for advance directives, but most are readily available on the internet or from healthcare providers.

"Emotionally, the burden of not having a living will can be even greater on your loved ones than not having a will after death," says Hoverman. "Don't leave it up to your family to have to make these tough decisions for you."

For more information on advance care planning, or living wills, visit the patient section at www.usoncology.com.

About US Oncology

US Oncology, Inc., headquartered in the Houston area, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,211 physicians operating in 456 locations, including 94 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. US Oncology Clinical Development Attends Partnerships With CROs
2. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
3. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
4. US Oncology Provides Full Service Management of Clinical Trials
5. Van Andel Institute Joins the MetaMiner Oncology Partnership Program
6. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
7. Palonosetron Warrants Adequate Caloric Intake in Oncology Patients Receiving High Emetogenic Chemotherapy
8. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
9. US Oncology Named to FORTUNE Magazines Most Admired Companies List for Third Time
10. Campbell Alliance Brand Management Practice to Present at EyeForPharmas Oncology Summit USA and Oncology Market Access Europe Conference
11. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The ... by the Office of the National Coordinator for Health IT (ONC) outlining a ... clinically relevant data were available when and where it was needed. The organization ...
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies ... will be accelerated by research at Worcester Polytechnic Institute (WPI) that yielded a ... and tissue regeneration. , The novel method, developed by WPI faculty members Raymond ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... Precision Farming in 2017 and Beyond. The paper outlines the key trends that ... ag industry. , “We’ve witnessed a lot of highs and lows as the ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... on molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman Prizes. ... are given in two categories, one for experiment and the other for theory ...
Breaking Biology Technology:
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/18/2016)... , March 18, 2016 --> ... of Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and ... security companies in the border security market and the continuing ... and Europe has led visiongain to ... improved success. --> defence & security companies ...
(Date:3/14/2016)... MELBOURNE, Florida , March 14, 2016 ... on the growing mobile commerce market, announces the airing of ... York channels starting the week of March 21 st . ... and CNBC, including its popular Squawk on the Street show. ... company focused on the growing mobile commerce market, announces the ...
Breaking Biology News(10 mins):